Next Article in Journal
5-bp Classical Satellite DNA Loci from Chromosome-1 Instability in Cervical Neoplasia Detected by DNA Breakage Detection/Fluorescence in Situ Hybridization (DBD-FISH)
Next Article in Special Issue
Diagnosis of Desmoplastic Reaction by Immunohistochemical Analysis, in Biopsy Specimens of Early Colorectal Carcinomas, Is Efficacious in Estimating the Depth of Invasion
Previous Article in Journal
Anti-Proliferative Activities and Apoptosis Induction by Triterpenes Derived from Eriobotrya japonica in Human Leukemia Cell Lines
Int. J. Mol. Sci. 2013, 14(2), 4121-4134; doi:10.3390/ijms14024121
Article

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

1,2,†
, 3,4,5,6,†
, 7
, 8,9
 and 8,9,*
Received: 9 November 2012; in revised form: 9 December 2012 / Accepted: 25 January 2013 / Published: 19 February 2013
(This article belongs to the Special Issue Pathogenesis and Prevention of Colorectal Cancer)
View Full-Text   |   Download PDF [202 KB, uploaded 19 June 2014]
Abstract: Using the comprehensive approach to selecting polymorphisms to date, we sought to examine whether recurrence in colorectal cancer was associated with inherited variation in three genes involved in DNA repair and cell proliferation. Three polymorphisms, which are excision repair cross-complementation 1 (ERCC1), xeroderma pigmentosum group D (XPD) and epidermal growth factor receptor (EGFR), were assessed in 257 postoperative stage II/III CRC patients with 5-fluorouracial chemotherapy in Taiwan. In addition, the correlations between genetic polymorphisms and patients’ clinicopathological features were investigated. Genotypes of XPD codon751 A/A and ERCC1 codon118 T/T were associated with regional recurrence in a statistically significant way (p = 0.018). Patients who carried XPD AA and ERCC1 TT genotypes demonstrated a significantly greater regional recurrence risk (OR = 5.625, 95% CI, 1.557–20.32). Inherited variation in XPD and ERCC1 was associated with outcome in patients with colorectal cancer in Taiwan. As the significant association of single-nucleotide polymorphisms has not been studied previously in colorectal cancer, these findings suggest novel sites of variation, in part explaining the range of treatment responses seen in this disease.
Keywords: genetic polymorphism; XPD; ERCC1; colorectal cancer; regional recurrence genetic polymorphism; XPD; ERCC1; colorectal cancer; regional recurrence
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Huang, M.-Y.; Wang, J.-Y.; Huang, M.-L.; Chang, H.-J.; Lin, S.-R. Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome. Int. J. Mol. Sci. 2013, 14, 4121-4134.

AMA Style

Huang M-Y, Wang J-Y, Huang M-L, Chang H-J, Lin S-R. Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome. International Journal of Molecular Sciences. 2013; 14(2):4121-4134.

Chicago/Turabian Style

Huang, Ming-Yii; Wang, Jaw-Yuan; Huang, Meng-Lin; Chang, Hui-Jen; Lin, Shiu-Ru. 2013. "Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome." Int. J. Mol. Sci. 14, no. 2: 4121-4134.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert